Researchers conducted a secret shopper study, evaluating 49 websites offering GLP-1 medications, to assess prescribing practices, clinician involvement, and quality of care.

A new study found that calls to poison control centers involving popular GLP-1 weight-loss drugs climbed sharply after semaglutide was approved for obesity in 2021, with most cases linked to medication mistakes that could have been avoided.

Researchers found adults taking GLP-1 drugs alongside multiple blood pressure medications experience more low blood pressure-related episodes, including fainting and falls.

A new study identifies the best eating patterns for battling weight gain and improving cardiometabolic health during menopause.

In a new study, patients with 4 types of obesity-related cancer who were taking a GLP-1 medication were significantly less likely to see their cancer progress to stage 4.

In a new study, overweight and obese adults assigned to a rapid weight loss plan lost more pounds — and kept more off after one year — than those following a gradual approach.

A major women’s health condition affecting more than 170 million women worldwide has been renamed PMOS in an effort to improve diagnosis, awareness, and long-term care.

In a new study, breast cancer patients using GLP-1 medications for obesity and/or diabetes had a lower risk of recurrence and death over 10 years of follow-up.

A new study of nearly 4,000 adults found that people who increased their daily walking to about 8,500 steps during dieting — and maintained it afterwards — were more successful at keeping the pounds off long term.

A new study suggests people who exercise in the early morning have lower risks of coronary artery disease, high blood pressure, diabetes and obesity.

A large, new evidence review finds intermittent fasting may not help overweight or obese patients loose a significant amount of weight or improve their quality of life.

HealthDay takes you on a tour of the Yale Teaching Kitchen, where patients with diabetes, heart disease, obesity and more learn to cook for life.

A new study finds when people start taking GLP-1 medications, spending at grocery stores and restaurants changes.

A new study suggests GLP-1 medications may reduce the need for CPAP machines in people with obesity, diabetes and sleep apnea.

A review of 48 clinical trials on GLP-1 safety suggests the popular meds probably have little to no effect on cancer risk.

CMK syndrome links heart, kidney and metabolic risk factors and the American Heart Association says it’s extremely common in U.S. adults.

Researchers analyzed cancer trends in 42 countries and found a surge in certain cancer types in both young and older adults – with one exception.

1 in 5 women and 1 in 10 men from Generation X and the tail end of the Baby Boom meet the criteria for addiction to ultra-processed foods, researchers say.

Researchers compare three hotly debated time policies and find a surprising winner when it comes to improving health outcomes for millions of people.

In a new study, people with metabolic syndrome were 40% more likely to be diagnosed with Parkinson’s disease. Metabolic Syndrome is a cluster of conditions that increase the risk of heart disease, stroke and type 2 diabetes.

A new study finds women with obesity who lose weight before IVF have increased odds of getting pregnant, especially through natural conception.

People who quit taking anti-obesity meds, including popular GLP-1 receptor agonists, may regain a significant amount of weight after eight weeks, a new study finds.